Polymorphisms in MIR27A Associated with Early-Onset Toxicity in Fluoropyrimidine-Based Chemotherapy

Overview of attention for article published in Clinical Cancer Research, April 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter: 3 X users

guideline: 1 clinical guideline source

Readers on

mendeley: 49 Mendeley

So far, Altmetric has seen 1 Guideline that references this research output.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update

Clinical guideline published by Clinical Pharmacogenetics Implementation Consortium (CPIC) on 20 Nov 2017

The Clinical Pharmacogenetics Implementation Consortium (CPIC) is an international group dedicated to enhancing the use of pharmacogenetic testing in clinical settings. They develop and share peer-reviewed, evidence-based guidelines to aid healthcare providers in making informed prescribing decisions based on genetic test results.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.